And so back to colostomy bags, catheters and insulin pumps, and to Convatec — the medical equipment maker and specialist in chronic wounds — whose life on the stock market came with some early wobbles and rapidly became much worse.
The last time that this column looked at this company, it concluded that it had some serious potential but was suffering from a bad credibility problem. Having concluded in early August that the shares should be avoided, they have since lost almost 16 per cent of their value.
Much has happened in the interim, including an overhaul of pretty much the entire management team and the introduction of a back-to-basics plan to get the company moving again and win back the trust of investors. But